BR0015647A - Uso de um antagonista de h1 e um esteróide seguro para tratar condições dos olhos - Google Patents

Uso de um antagonista de h1 e um esteróide seguro para tratar condições dos olhos

Info

Publication number
BR0015647A
BR0015647A BR0015647-7A BR0015647A BR0015647A BR 0015647 A BR0015647 A BR 0015647A BR 0015647 A BR0015647 A BR 0015647A BR 0015647 A BR0015647 A BR 0015647A
Authority
BR
Brazil
Prior art keywords
antagonist
eye conditions
treat eye
safe
safe steroid
Prior art date
Application number
BR0015647-7A
Other languages
English (en)
Inventor
John M Yanni
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0015647A publication Critical patent/BR0015647A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

"USO DE UM ANTAGONISTA DE H~ 1~, E UM ESTERóIDE SEGURO PARA TRATAR CONDIçõES DOS OLHOS". São reveladas composições e processos para tratamento de VKC, GPC e AKC com antagonistas de H~ 1~, e esteróides ocularmente seguros.
BR0015647-7A 1999-11-18 2000-10-26 Uso de um antagonista de h1 e um esteróide seguro para tratar condições dos olhos BR0015647A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16619499P 1999-11-18 1999-11-18
PCT/US2000/029436 WO2001035963A1 (en) 1999-11-18 2000-10-26 Use of h1 antagonist and a safe steroid to treat eye conditions

Publications (1)

Publication Number Publication Date
BR0015647A true BR0015647A (pt) 2002-07-16

Family

ID=22602196

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015647-7A BR0015647A (pt) 1999-11-18 2000-10-26 Uso de um antagonista de h1 e um esteróide seguro para tratar condições dos olhos

Country Status (12)

Country Link
US (1) US6649602B1 (pt)
EP (1) EP1242090A4 (pt)
CN (1) CN1376066A (pt)
AU (1) AU772406B2 (pt)
BR (1) BR0015647A (pt)
CA (1) CA2380532A1 (pt)
HK (1) HK1047699A1 (pt)
MX (1) MXPA02005007A (pt)
PL (1) PL355101A1 (pt)
TR (1) TR200201322T2 (pt)
WO (1) WO2001035963A1 (pt)
ZA (1) ZA200201903B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
ES2258175T3 (es) * 2001-12-05 2006-08-16 Alcon, Inc. Utilizacion de un antagonista de h1 y remixolona como esteroide inofensivo para el tratamiento de la rinitis.
PL373433A1 (en) 2002-08-30 2005-08-22 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
BR0316203A (pt) * 2002-11-12 2005-10-04 Alcon Inc Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
US20050239745A1 (en) * 2004-03-03 2005-10-27 Ophthalmic Research Associates, Inc. Novel topical ophthalmic formulations
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
WO2006047418A1 (en) * 2004-10-25 2006-05-04 Alimera Sciences, Inc. Ophthalmic compositions and methods of using the same
DK2486942T3 (en) 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US20110104159A1 (en) * 2006-09-11 2011-05-05 Rohrs Brian R Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
US20110105559A1 (en) * 2006-09-11 2011-05-05 Rohrs Brian R Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
PL2061444T3 (pl) * 2006-09-11 2011-09-30 Bausch & Lomb Kompozycje i sposoby leczenia, traktowania, kontrolowania, redukowania, łagodzenia lub zapobiegania alergii
EP2222299B1 (en) * 2007-11-19 2011-11-23 Bausch & Lomb Incorporated Use of levocabastine for modulating generation of pro-inflammatory cytokines
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
WO2010107525A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic formulations of ketotifen and methods of use
CA2755679C (en) 2009-03-17 2017-09-12 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US20130023520A1 (en) * 2011-07-24 2013-01-24 Amir Sahba Jalali Anaesthetic eye solution and method of use
WO2013061269A1 (en) * 2011-10-26 2013-05-02 Micro Labs Limited Combinations of loteprednol and olopatadine for the treatment of ocular allergies
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US5149694A (en) 1988-03-09 1992-09-22 Alcon Laboratories, Inc. Combination of tobramycin and dexamethasone for topical ophthalmic use
US5192780A (en) 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
US5668133A (en) 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5420120A (en) 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use

Also Published As

Publication number Publication date
ZA200201903B (en) 2003-05-28
CA2380532A1 (en) 2001-05-25
US6649602B1 (en) 2003-11-18
TR200201322T2 (tr) 2002-11-21
EP1242090A4 (en) 2004-02-11
CN1376066A (zh) 2002-10-23
WO2001035963A1 (en) 2001-05-25
HK1047699A1 (zh) 2003-03-07
EP1242090A1 (en) 2002-09-25
MXPA02005007A (es) 2004-08-12
AU4610101A (en) 2001-05-30
PL355101A1 (en) 2004-04-05
AU772406B2 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
HK1047699A1 (zh) H1拮抗剂及安全的类固醇用在治疗眼疾的用途
WO2002030462A3 (en) Hedgehog antagonists, methods and uses related thereto
AU2003301020A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
IL143901A0 (en) Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
BR0010061A (pt) Tratamento de fibrose por antagonista de il-13 e cadeias de receptor il-13
MY133571A (en) Compositions and methods for treating conditions responsive to estrogen.
BR0016166A (pt) Compostos de diidropirimidina heterocìclicos
TR200100671T1 (tr) Antiviral indoloksoasetil piperazin türevleri
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
DE69814049D1 (de) Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore
DE69821132T2 (de) 1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes
BR9913800A (pt) Método para tratar glaucoma, e, composição para tratar glaucoma
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
DE60137966D1 (de) Anilinopyrimidin derivate als "jnk pathway inhibitoren", zusammensetzungen und damit verbundene behandlungsmethoden
WO2002046171A3 (en) Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
BR9811099A (pt) Inibidores de urocinase
AU2059499A (en) Use of heterocyclic quaternary polyammonium polymers as protective agent for keratin fibres and cosmetic compositions
BR0007864A (pt) Composto, e, uso de um composto
NZ329807A (en) NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
BR0014355A (pt) Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
BR9811298A (pt) Uso de um composto de vanádio fisiologicamente aceitável
BR0004535A (pt) Compostos, e, uso dos mesmos.
PT684816E (pt) Composicoes antagonistas do receptor da 5-ht2 uteis no tratamento de doencas venosas
MXPA04005417A (es) Uso de antagonista de h1 y un esteroide seguro para el tratamiento de la rinitis.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10(VIII) DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.